Report for: Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Title	Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes
Published in	medRxiv, January 2022
DOI	10.1101/2021.12.30.21268565
Authors	Buchan, Sarah A., Chung, Hannah, Brown, Kevin A., Austin, Peter C., Fell, Deshayne B., Gubbay, Jonathan B., Nasreen, Sharifa, Schwartz, Kevin L., Sundaram, Maria E., Tadrous, Mina, Wilson, Kumanan, Wilson, Sarah E., Kwong, Jeffrey C., Sarah A. Buchan, Hannah Chung, Kevin A. Brown, Peter C. Austin, Deshayne B. Fell, Jonathan B. Gubbay, Sharifa Nasreen, Kevin L. Schwartz, Maria E. Sundaram, Mina Tadrous, Kumanan Wilson, Sarah E. Wilson, Jeffrey C. Kwong, on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 16,041 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
Japan	1445	9%
United States	1085	7%
Canada	753	5%
France	633	4%
Germany	340	2%
United Kingdom	184	1%
Netherlands	88	<1%
Italy	75	<1%
Australia	72	<1%
Other	906	6%
Unknown	10460	65%

Demographic breakdown

Type	Count	As %
Members of the public	15524	97%
Scientists	213	1%
Practitioners (doctors, other healthcare professionals)	196	1%
Science communicators (journalists, bloggers, editors)	95	<1%
Unknown	13	<1%

Attention Score in Context

This research output has an Altmetric Attention Score of 8768. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2023.

All research outputs

#259

of 23,979,422 outputs

Outputs from medRxiv

#19

of 42,739 outputs

Outputs of similar age

#26

of 517,456 outputs

Outputs of similar age from medRxiv

of 1,655 outputs

Altmetric has tracked 23,979,422 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 42,739 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 54.4. This one has done particularly well, scoring higher than 99% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 517,456 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.

We're also able to compare this research output to 1,655 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.

medRxiv

Article Metrics

Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

About this Attention Score

Mentioned by

Citations

Twitter Demographics

Geographical breakdown

Demographic breakdown

Attention Score in Context